$1.24
0.065.08%
At close: -
$1.21
-0.03-2.42%
After Hours: Apr 17, 6:03 PM EDT
Comments
Loading...
Taysha Gene Therapies Earnings Estimates, EPS & Revenue | NASDAQ:TSHA | Benzinga
Taysha Gene Therapies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 26
EPS
$-0.070
Quarterly Revenue
$2.02M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$8.33M
Analyze the earnings history of Taysha Gene Therapies using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies | -$0.10 | — | — | — | $3.41M | — | — | — | 05/13/2025 | Get Alert |
| TSHA | Taysha Gene Therapies | $0.92 | -$0.08 | -$0.07 | 12.50% | $3.60M | $1.90M | $2.02M | 6.42% | 02/26/2025 | Get Alert |
| TSHA | Taysha Gene Therapies | -$0.93 | -$0.09 | -$0.10 | -11.11% | $4.75M | $1.65M | $1.79M | 8.36% | 11/13/2024 | Get Alert |
| TSHA | Taysha Gene Therapies | -$0.38 | -$0.17 | -$0.09 | 47.06% | $2.40M | $2.66M | $1.11M | -58.20% | 08/12/2024 | Get Alert |
| TSHA | Taysha Gene Therapies | -$0.28 | -$0.11 | -$0.10 | 9.09% | $4.71M | $2.56M | $3.41M | 33.24% | 05/14/2024 | Get Alert |
| TSHA | Taysha Gene Therapies | -$0.34 | -$0.11 | $0.92 | 936.36% | $2.50M | $2.65M | $3.60M | 36.00% | 03/19/2024 | Get Alert |
| TSHA | Taysha Gene Therapies | -$0.64 | -$0.17 | -$0.93 | -447.06% | $0.00 | $1.40M | $4.75M | 239.00% | 11/14/2023 | Get Alert |
| TSHA | Taysha Gene Therapies | -$0.84 | -$0.31 | -$0.38 | -22.58% | $0.00 | $2.00M | $2.40M | 19.75% | 08/14/2023 | Get Alert |
| TSHA | Taysha Gene Therapies | -$1.31 | -$0.35 | -$0.28 | 20.00% | $0.00 | $70.00K | $4.71M | 6622.86% | 05/11/2023 | Get Alert |
| TSHA | Taysha Gene Therapies | -$1.32 | -$0.33 | -$0.34 | -3.03% | $0.00 | $8.18M | $2.50M | -69.41% | 03/28/2023 | Get Alert |
| TSHA | Taysha Gene Therapies | -$1.35 | -$0.82 | -$0.64 | 21.95% | $0.00 | — | $0.00 | — | 11/08/2022 | Get Alert |
| TSHA | Taysha Gene Therapies | -$1.09 | -$0.91 | -$0.84 | 7.69% | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
| TSHA | Taysha Gene Therapies | -$0.87 | -$1.07 | -$1.31 | -22.43% | $0.00 | — | $0.00 | — | 05/16/2022 | Get Alert |
| TSHA | Taysha Gene Therapies | -$1.04 | -$1.25 | -$1.32 | -5.60% | $0.00 | — | $0.00 | — | 03/31/2022 | Get Alert |
| TSHA | Taysha Gene Therapies | -$1.28 | -$1.08 | -$1.35 | -25.00% | $0.00 | — | $0.00 | — | 11/10/2021 | Get Alert |
| TSHA | Taysha Gene Therapies | — | -$0.84 | -$1.09 | -29.76% | — | — | $0.00 | — | 08/16/2021 | Get Alert |
| TSHA | Taysha Gene Therapies | — | -$0.56 | -$0.87 | -55.36% | — | — | $0.00 | — | 05/11/2021 | Get Alert |
| TSHA | Taysha Gene Therapies | — | -$0.37 | -$1.04 | -181.08% | — | — | $0.00 | — | 03/03/2021 | Get Alert |
| TSHA | Taysha Gene Therapies | — | — | -$1.28 | — | — | — | $0.00 | — | 11/12/2020 | Get Alert |
Taysha Gene Therapies (TSHA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $-0.07 | $-0.08 | 12.5 % |
| Q3 | 2024-11-13 | $-0.10 | $-0.09 | -11.1 % |
| Q2 | 2024-08-12 | $-0.09 | $-0.17 | 47.1 % |
| Q1 | 2024-05-14 | $-0.10 | $-0.11 | 9.09 % |
Taysha Gene Therapies (TSHA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $2.02M | $1.90M | 6.42 % |
| Q3 | 2024-11-13 | $1.79M | $1.65M | 8.36 % |
| Q2 | 2024-08-12 | $1.11M | $2.66M | -58.2 % |
| Q1 | 2024-05-14 | $3.41M | $2.56M | 33.2 % |
FAQ
When is Taysha Gene Therapies (NASDAQ:TSHA) reporting earnings?
Taysha Gene Therapies (TSHA) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.
What were the latest earnings per share (EPS) for Taysha Gene Therapies (NASDAQ:TSHA)?
The Actual EPS was $-0.07, which beat the estimate of $-0.08.
What were Taysha Gene Therapies’s (NASDAQ:TSHA) revenues?
The Actual Revenue was $2M, which beat the estimate of $1.9M.
Browse earnings estimates, EPS, and revenue on all stocks.
